MariposAI

Company Overview

Snapshot

Founded in November 2025 by Noam Shomron and Oria Altman, MariposAI operates with 1-10 employees. The company is currently in its Pre-Funding stage, focusing on developing its core technology.

Business overview

MariposAI is a Health Tech & Life Sciences company specializing in Digital Medical Diagnostics within the Digital Healthcare sector. The company develops a continuous learning AI system designed to identify breast cancer risks significantly earlier than traditional methods. Its proprietary algorithm analyzes extensive longitudinal health data to detect subtle physiological patterns preceding symptomatic stages, aiming to shift oncology from reactive treatment to proactive monitoring. The system integrates with existing healthcare databases to provide scalable, data-driven insights for clinical decision support.

Company Intelligence Q&A

What is MariposAI's primary focus?

MariposAI focuses on developing a continuous learning AI system for the early detection of breast cancer signals, aiming to improve patient outcomes through proactive monitoring.

When was MariposAI founded?

MariposAI was founded in November 2025.

Who are the founders of MariposAI?

MariposAI was founded by Noam Shomron and Oria Altman.

What technology does MariposAI utilize?

MariposAI utilizes a proprietary algorithm and artificial intelligence, specifically generative AI, to analyze longitudinal health data for early breast cancer detection.

What is MariposAI's current product stage?

MariposAI is currently in the R&D stage for its product development, focusing on refining its core AI algorithm and preparing for initial clinical trials.